•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A08383 Summary:

BILL NOA08383A
 
SAME ASSAME AS S07823-A
 
SPONSORLasher
 
COSPNSRPaulin, McDonald, Magnarelli, Lupardo, Seawright, Rosenthal, Schiavoni, Romero, Carroll R
 
MLTSPNSR
 
Amd §6801, Ed L; amd §2164, Pub Health L
 
Authorizes a licensed pharmacist to administer any recommendations made by the commissioner of health pertaining to a vaccine that has been authorized by the federal Food and Drug Administration; removes the requirement to follow the advisory committee on immunization practices of the centers for disease control and prevention recommendation for immunization against meningococcal disease.
Go to top

A08383 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         8383--A
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                      May 13, 2025
                                       ___________
 
        Introduced  by  M.  of A. LASHER, PAULIN, McDONALD, MAGNARELLI, LUPARDO,
          SEAWRIGHT, ROSENTHAL -- read once and referred  to  the  Committee  on
          Health  --  committee  discharged,  bill amended, ordered reprinted as
          amended and recommitted to said committee
 
        AN ACT to amend the education law, in relation to authorizing the admin-
          istration of immunizations pursuant to  recommendations  made  by  the
          commissioner  of  health;  and  to  amend  the  public  health law, in
          relation to removing the requirement to follow the centers for disease
          control and prevention recommendation for immunization against  menin-
          gococcal disease
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Subparagraph (e) of paragraph 2  of  section  6801  of  the
     2  education  law,  as amended by section 1 of part DD of chapter 57 of the
     3  laws of 2018, is amended to read as follows:
     4    (e) administer the immunization or immunizations according to the most
     5  current recommendations by the advisory committee for immunization prac-
     6  tices (ACIP), or,  in  the  alternative,  recommendations  made  by  the
     7  commissioner  of health pertaining to a vaccine that has been authorized
     8  by the Food and Drug Administration, provided however, that a pharmacist
     9  may administer any immunization authorized under this section when spec-
    10  ified by a patient specific order.
    11    § 2. Subparagraph a of paragraph 4 of section 6801  of  the  education
    12  law,  as  amended  by  section 1 of part DD of chapter 57 of the laws of
    13  2018, is amended to read as follows:
    14    [a.] (a) a clearly visible posting of the  most  current  "Recommended
    15  Adult  Immunization  Schedule"  published  by the advisory committee for
    16  immunization practices (ACIP) and any supplemental  schedules  published
    17  by the commissioner of health; and
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11946-03-5

        A. 8383--A                          2
 
     1    § 3. Paragraph c of subdivision 2 of section 2164 of the public health
     2  law,  as added by chapter 401 of the laws of 2015, is amended to read as
     3  follows:
     4    c. Every person in parental relation to a child in this state entering
     5  or  having  entered  seventh grade and twelfth grade or a comparable age
     6  level special education program with an unassigned  grade  on  or  after
     7  September  first,  two thousand sixteen, shall have administered to such
     8  child an adequate dose or doses of immunizing agents against meningococ-
     9  cal disease [as recommended by the advisory  committee  on  immunization
    10  practices  of  the  centers  for  disease control and prevention,] which
    11  meets the standards approved by the United States public health  service
    12  for  such  biological  products, and which is approved by the department
    13  under such conditions as may be specified by the public health and plan-
    14  ning council.
    15    § 4. This act shall take effect immediately.
Go to top